RedHill Biopharma Ltd. (RDHL) Form 6-K — Jun 29, 2026

$RDHLForm 6-KFiled Jun 29, 2026, 7:00 AM ET0001178913-26-003351Original filing

RedHill Biopharma Ltd. filed a prospectus supplement to increase the maximum aggregate offering amount of its American Depositary Shares under an existing At The Market Offering Agreement with H.C. Wainwright & Co., LLC. The aggregate offering price for the Placement ADSs has been increased to up to $2,128,000, allowing the company to sell shares at market prices over time.

Key figures

Gross Proceeds: $2,128,000
Ads to ordinary ratio: 10000

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.